—Molbio Diagnostics, a molecular diagnostics solutions company, is proud to announce its investment of $30 million in OptraSCAN, a San Jose-based global diagnostics company. This strategic partnership underscores Molbio’s commitment to democratising healthcare by making advanced diagnostics accessible to underserved communities and healthcare providers worldwide. It enables OptraSCAN to accelerate the development and accessibility of digital pathology solutions powered by artificial intelligence. These solutions, which include cloud based systems for slide scanning, image analysis, and secure data storage, aim to facilitate faster, more accurate diagnoses.